Deoxyuridine monophosphate reverses resistance to 5FU in 5FU-resistant gastric cancer

被引：0
|
作者：
Mori, R. [1 ]
Tanahashi, T. [1 ]
Okumura, N. [1 ]
Yamaguchi, K. [1 ]
Futamura, M. [1 ]
Yoshida, K. [1 ]
机构：
[1] Gifu Univ, Grad Sch Med, Surg Oncol, Gifu, Japan
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
209P
引用
收藏
页码：63 / 63
页数：1
相关论文
共 50 条
  • [1] 5FU resistance caused by reduced fluoro-deoxyuridine monophosphate and its reversal using deoxyuridine
    Mori, Ryutaro
    Futamura, Manabu
    Tanahashi, Toshiyuki
    Tanaka, Yoshihiro
    Matsuhashi, Nobuhisha
    Yamaguchi, Kazuya
    Yoshida, Kazuhiro
    ONCOLOGY LETTERS, 2017, 14 (03) : 3162 - 3168
  • [2] Mechanism of acquired 5FU resistance and strategy for overcoming 5FU resistance focusing on 5FU metabolism in colon cancer cell lines
    Suetsugu, Tomonari
    Mori, Ryutaro
    Futamura, Manabu
    Fukada, Masahiro
    Tanaka, Hideharu
    Yasufuku, Itaru
    Sato, Yuta
    Iwata, Yoshinori
    Imai, Takeharu
    Imai, Hisashi
    Tanaka, Yoshihiro
    Okumura, Naoki
    Matsuhashi, Nobuhisa
    Takahashi, Takao
    Yoshida, Kazuhiro
    ONCOLOGY REPORTS, 2021, 45 (04)
  • [3] Protracted infusional 5FU+mitomycin in 5FU-resistant colorectal cancer.
    Chester, JD
    Dent, JT
    Wilson, G
    Ride, E
    Seymour, MT
    BRITISH JOURNAL OF CANCER, 1999, 80 : 55 - 55
  • [4] 5FU metabolic mechanism and overcoming acquired 5FU resistance in colon cancer cell lines
    Suetsugu, Tomonari
    Mori, Ryutaro
    Futamura, Manabu
    Fukada, Masahiro
    Yasufuku, Itaru
    Iwata, Yoshinori
    Imai, Takeharu
    Imai, Hisashi
    Tanaka, Yoshihiro
    Okumura, Naoki
    Matsuhashi, Nobuhisa
    Takahashi, Takao
    Yoshida, Kazuhiro
    CANCER SCIENCE, 2021, 112 : 715 - 715
  • [5] Chromosomal imbalance maps of human 5FU-resistant colorectal cancer cell lines: Implications in the analysis of 5FU-acquired resistance mechanisms
    Plasencia, C
    Rooney, PH
    Taron, M
    Martinez-Balibrea, E
    McLeod, HL
    Abad, A
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2003, 22 (05) : 945 - 953
  • [6] P-glycoprotein plays an important role in the cross-resistance to taxanes in 5FU-resistant gastric cancer cells
    Mori, Ryutaro
    Tanahashi, Toshiyuki
    Yawata, Kazunori
    Kato, Junko
    Okumura, Naoki
    Yamaguchi, Kazuya
    Futamura, Manabu
    Yoshida, Kazuhiro
    TRANSLATIONAL GASTROINTESTINAL CANCER, 2015, 4 (02) : 123 - 130
  • [7] Proteomics analysis of the effect of fluorouracil (5FU) and 5FU/leucovorin (LV) on colorectal cancer (CRC) in patients
    Smid, Kees
    Meijer, Erik
    Pham, Thang V.
    de Reus, Inge
    Piersma, Sander R.
    Peters, Godefridus J.
    Jimenez, Connie R.
    CANCER RESEARCH, 2015, 75
  • [8] Evaluating 5FU plasma level in colorectal cancer chemotherapy patients through continuous 5FU infusion
    Sakuyama, Naoki
    Sato, Tsuyoshi
    Kishine, Kenji
    Nagayasu, Kiichi
    Nakatani, Akinori
    Kitajima, Masayuki
    ANNALS OF ONCOLOGY, 2022, 33 : S542 - S542
  • [9] Intraocular pressure outcome in primary 5FU phacotrabeculectomies compared with 5FU trabeculectomies
    Chang, Lydia
    Thiagarajan, Manickam
    Moseley, Merrick
    Woodruff, Simon
    Bentley, Chris
    Khaw, Peng Tee
    Bloom, Philip
    JOURNAL OF GLAUCOMA, 2006, 15 (06) : 475 - 481
  • [10] Fluorouracil (5FU) pharmacokinetics in 5FU prodrug formulations with a dihydropyrimidine dehydrogenase inhibitor
    Peters, GJ
    van Groeningen, CJ
    Giaccone, G
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (22) : 4267 - 4268
12345